MIM Pharma team is composed of experienced biopharma executives with a drive for transfer the legacy of deep-rooted-natural medicine to the modern pharmaceutical R&D and manufacturing techniques for introducing novel medical solutions for common annoying diseases such as Covid-19, migraine, and migraine-related diseases. The research and development team have achieved very promising results in treating these diseases. MIM Pharma management combines a wealth of talent and international experience in drug discovery and commercialization.

Peter Ressalehi

Chief Executive Officer

Dr. Reza Ramazani

Director of Operations and Senior Researcher

Mona Hedvig Myhre

Chief Business consultant

Saleh Ramazani

Director of Lab and Drug formulation

Fateme Azadinia

Director of Clinical Operations